148 related articles for article (PubMed ID: 2612615)
1. Use of the ferritin/alanine aspartate transaminase ratio as an iron overload marker independent of liver cell damage.
Triadou P; Regnat-Lusinchi A; Girot R
Eur J Haematol; 1989 Nov; 43(5):423-7. PubMed ID: 2612615
[TBL] [Abstract][Full Text] [Related]
2. Liver affection in iron overload studied with serum ferritin and serum aminotransferases.
Olsson KS; Ritter B; Lundin PM
Acta Med Scand; 1985; 217(1):79-84. PubMed ID: 3976436
[TBL] [Abstract][Full Text] [Related]
3. Effect of deferiprone on liver iron overload and fibrosis in hepatitis-C-virus-infected thalassemia.
Chen AC; Peng CT; Wu SF; Wu KH; Chiang IP; Tsai CH
Hemoglobin; 2006; 30(2):209-14. PubMed ID: 16798645
[TBL] [Abstract][Full Text] [Related]
4. Iron chelation in transfusion-dependent thalassemia with chronic hepatitis.
De Virgiliis S; Cossu P; Sanna G; Frau F; Loi E; Lobrano R; Nucaro A; Toccafondi C; Cornacchia G; Loi A; Cao A
Acta Haematol; 1982; 67(1):49-56. PubMed ID: 6800202
[TBL] [Abstract][Full Text] [Related]
5. Binding of serum ferritin to concanavalin A: patients with homozygous beta thalassaemia and transfusional iron overload.
Worwood M; Cragg SJ; Jacobs A; McLaren C; Ricketts C; Economidou J
Br J Haematol; 1980 Nov; 46(3):409-16. PubMed ID: 7448126
[TBL] [Abstract][Full Text] [Related]
6. Serum ferritin in patients with iron overload and with acute and chronic liver diseases.
Prieto J; Barry M; Sherlock S
Gastroenterology; 1975 Mar; 68(3):525-33. PubMed ID: 1112454
[TBL] [Abstract][Full Text] [Related]
7. On the iron content of human serum ferritin, especially in acute viral hepaptitis and iron overload.
Zuyderhoudt FM; Linthorst C; Hengeveld P
Clin Chim Acta; 1978 Nov; 90(1):93-9. PubMed ID: 719893
[TBL] [Abstract][Full Text] [Related]
8. Improvement in iron status and liver function in patients with transfusional iron overload with long-term subcutaneous desferrioxamine.
Hoffbrand AV; Gorman A; Laulicht M; Garidi M; Economidou J; Georgipoulou P; Hussain MA; Flynn DM
Lancet; 1979 May; 1(8123):947-9. PubMed ID: 87616
[TBL] [Abstract][Full Text] [Related]
9. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.
Fujita N; Sugimoto R; Takeo M; Urawa N; Mifuji R; Tanaka H; Kobayashi Y; Iwasa M; Watanabe S; Adachi Y; Kaito M
Mol Med; 2007; 13(1-2):97-104. PubMed ID: 17515961
[TBL] [Abstract][Full Text] [Related]
10. Estimating iron overload in patients with suspected liver disease and elevated serum ferritin.
Cippà PE; Boucsein I; Adams H; Krayenbuehl PA
Am J Med; 2014 Oct; 127(10):1011.e1-3. PubMed ID: 24662623
[TBL] [Abstract][Full Text] [Related]
11. Quantification of liver iron overload by T2 quantitative magnetic resonance imaging in thalassemia: impact of chronic hepatitis C on measurements.
Papakonstantinou O; Kostaridou S; Maris T; Gouliamos A; Premetis E; Kouloulias V; Nakopoulou L; Kattamis C
J Pediatr Hematol Oncol; 1999; 21(2):142-8. PubMed ID: 10206461
[TBL] [Abstract][Full Text] [Related]
12. Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*.
Kolnagou A; Economides C; Eracleous E; Kontoghiorghes GJ
Hemoglobin; 2006; 30(2):219-27. PubMed ID: 16798647
[TBL] [Abstract][Full Text] [Related]
13. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease.
Kalpatthi R; Peters B; Kane I; Holloman D; Rackoff E; Disco D; Jackson S; Laver JH; Abboud MR
Pediatr Blood Cancer; 2010 Dec; 55(7):1338-42. PubMed ID: 20981690
[TBL] [Abstract][Full Text] [Related]
15. Serum ferritin in children with thalassaemia regularly transfused.
Letsky EA; Miller F; Worwood M; Flynn DM
J Clin Pathol; 1974 Aug; 27(8):652-5. PubMed ID: 4421996
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of serum ferritin determination for hepatocellular carcinoma.
Nakano S; Kumada T; Sugiyama K; Watahiki H; Takeda I
Am J Gastroenterol; 1984 Aug; 79(8):623-7. PubMed ID: 6205585
[TBL] [Abstract][Full Text] [Related]
17. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.
Pakbaz Z; Fischer R; Fung E; Nielsen P; Harmatz P; Vichinsky E
Pediatr Blood Cancer; 2007 Sep; 49(3):329-32. PubMed ID: 17554789
[TBL] [Abstract][Full Text] [Related]
18. Binding of serum ferritin to concanavalin A in patients with iron overload and with chronic liver disease.
Chapman RW; Gorman A; Laulicht M; Hussain MA; Sherlock S; Hoffbrand AV
J Clin Pathol; 1982 May; 35(5):481-6. PubMed ID: 7085891
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
[TBL] [Abstract][Full Text] [Related]
20. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
